Nicholas Investment Partners, LP Vertex Pharmaceuticals Inc Transaction History

Nicholas Investment Partners, LP

$900 Million
Q3 2024

A detailed history of Nicholas Investment Partners, LP transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 1,253 shares of VRTX stock, worth $565,065. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,253

Previous 5,636 77.77%

Holding current value

$565,065

Previous $2.64 Million 77.96%

% of portfolio

0.06%

Previous 0.31%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $2.02 Million - $2.22 Million	-4,383 Reduced 77.77%	1,253 $582,000
Q2 2024 Aug 07, 2024	BUY	$392.81 - $485.53 $507,903 - $627,790	1,293 Added 29.77%	5,636 $2.64 Million
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $1.42 Million - $1.55 Million	-3,479 Reduced 44.48%	4,343 $1.82 Million
Q4 2023 Feb 07, 2024	SELL	$343.0 - $410.68 $29.8 Million - $35.7 Million	-86,936 Reduced 91.75%	7,822 $3.18 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $4.95 Million - $5.31 Million	14,642 Added 18.28%	94,758 $33 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $3.2 Million - $3.58 Million	-10,175 Reduced 11.27%	80,116 $28.2 Million
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $11.9 Million - $13.6 Million	42,050 Added 87.17%	90,291 $28.4 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $4.15 Million - $4.67 Million	-14,538 Reduced 23.16%	48,241 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $194,419 - $216,926	710 Added 1.14%	62,779 $18.2 Million
Q1 2022 May 10, 2022	BUY	$221.42 - $260.97 $5.27 Million - $6.21 Million	23,782 Added 62.12%	62,069 $16.2 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $6.78 Million - $8.56 Million	38,287 New	38,287 $8.41 Million
Q2 2019 Aug 09, 2019	SELL	$164.61 - $190.37 $2.34 Million - $2.71 Million	-14,214 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $1.88 Million - $2.24 Million	11,489 Added 421.61%	14,214 $2.62 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $22,634 - $28,639	149 Added 5.78%	2,725 $452,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $432,072 - $496,498	2,576 New	2,576 $496,000
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $4.77 Million - $5.56 Million	-32,709 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $958,870 - $1.12 Million	6,325 Added 23.97%	32,709 $5.33 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $1.88 Million - $2.13 Million	-13,667 Reduced 34.12%	26,384 $3.95 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $5.93 Million - $6.5 Million	40,051	40,051 $6.09 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account

Nicholas Investment Partners, LP Vertex Pharmaceuticals Inc Transaction History